Skip to main content
Clinical Trials/NCT01820169
NCT01820169
Terminated
Not Applicable

Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG

Hoffmann-La Roche0 sites2 target enrollmentApril 2013
ConditionsDiabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes
Sponsor
Hoffmann-La Roche
Enrollment
2
Primary Endpoint
Improvement in HbA1c in 6 months
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

This clinical study is to determine if the use of structured testing, which is a blood glucose monitoring, via the Accu-Chek 360° View blood glucose analysis tool has a positive effect on the subjects overall glycemic control.

Registry
clinicaltrials.gov
Start Date
April 2013
End Date
December 2013
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age:= and \>20 years.
  • Intend to paticipate in this study after education of structured testing. 3.HbA1c:= and \>7.5% in the recect 2 months.

Exclusion Criteria

  • 1.Pregancy.
  • Heavy complication
  • judged unsuitable by doctor

Outcomes

Primary Outcomes

Improvement in HbA1c in 6 months

Time Frame: 6 months

Secondary Outcomes

  • 4. Occurance of sever hypoglycemia.(Baseline to 6 months)
  • 1. Comparison with historical control in HbA1c change.(Baseline to 6 months)
  • 5. Doctor's opinion for Accu-Chek 360° View.(Baseline to 6 months)
  • 3. Change in BMI.(Baseline to 6 months)
  • 2. Change in blood gulucose.(Baseline to 6 months)

Similar Trials